Showing results (11-20 of 52) with videos related to
Sort By:
Pageof 6
Lung Cancer (Amsterdam, Netherlands)|January 22, 2025
Clinical utility of comprehensive genomic profiling in non-small cell lung cancer: An analysis of a nation-wide databaseKoki Fujii, Michiko Ueki, Momoko Morishita, et al.Biochemical and Biophysical Research Communications|August 3, 2010
Treatment of PCR products with exonuclease I and heat-labile alkaline phosphatase improves the visibility of combined bisulfite restriction analysisKousuke Watanabe, Noriko Emoto, Mitsuhiro Sunohara, et al.Cancer Science|March 27, 2025
Real-World Data Analysis of Genomic Alterations Detected by a Dual DNA-RNA Comprehensive Genomic Profiling TestKousuke Watanabe, Miho Ogawa, Aya Shinozaki-Ushiku, et al.Journal of Thoracic Imaging|September 14, 2011
Pulmonary venous invasion, determined by chest computed tomographic scan, as a potential early indicator of zygomycosis infection: a case seriesHiroshi Kitagawa, Kousuke Watanabe, Hidenori Kage, et al.Cancer Science|July 1, 2014
Alternative polyadenylation is associated with lower expression of PABPN1 and poor prognosis in non-small cell lung cancerJunji Ichinose, Kousuke Watanabe, Atsushi Sano, et al.IJU Case Reports|November 4, 2025
A Case of Metastatic Castration-Resistant Prostate Cancer With RAD54L Mutation Responding to NiraparibYusuke Sato, Yoichi Fujii, Masaki Nakamura, et al.IJU Case Reports|July 10, 2026
Metastatic Testicular Germ Cell Tumor in a Patient With Neurofibromatosis Type 1: Treatment With Trametinib Based on NF1 Gene MutationKeita Goto, Toshiki Kijima, Yusuke Sato, et al.Biochemical and Biophysical Research Communications|November 3, 2009
Impact of DNA demethylation of the G0S2 gene on the transcription of G0S2 in squamous lung cancer cell lines with or without nuclear receptor agonistsMasashi Kusakabe, Kousuke Watanabe, Noriko Emoto, et al.BMJ Open|March 12, 2022
Brief, manualised and semistructured individual psychotherapy programme for patients with advanced cancer in Japan: study protocol for Managing Cancer and Living Meaningfully (CALM) phase 2 trialSeraki Miyamoto, Tadahiro Yamazaki, Ken Shimizu, et al.NPJ Precision Oncology|March 19, 2026
Impact of BRAF, TERT, and novel mutations on the efficacy of lenvatinib for advanced papillary thyroid cancer: A national genomic database analysisYasuyoshi Sato, Naoki Fukuda, Koji Yamamura, et al.Pageof 6